When will Compass Pathways submit a NDA for COMP360 psilocybin?
As of Sat, 21 Nov 2026 06:08:47 UTC, Kalshi traders price before April 2027 (97.0%), before 2027 (97.0%), before December (96.0%). The market has $42K in volume and closes on Thu, 01 Apr 2027.
Updated:
Current odds
| Outcome | Chance | Yes price | No price |
|---|---|---|---|
| before April 2027 | 97.0% | 97.0¢ | 3.0¢ |
| before 2027 | 97.0% | 97.0¢ | 3.0¢ |
| before December | 96.0% | 96.0¢ | 4.0¢ |
Market details
- Venue: Kalshi
- Volume: $42K
- Liquidity: $42K
- Closes:
Resolution rules
Each outcome is a separate contract with its own rules. The rules for before April 2027:
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
Sources
Related markets
- When will the FDA reclassify BPC-157 to Category 1?
- Will the FDA approve retatrutide?
- Will the U.S. confirm that aliens exist?
- Best AI at the end of 2026?
- When will Anthropic release Mythos?
- Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
More markets like this
- When will the FDA approve Compass Pathways' COMP360 Psilocybin?
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will the FDA approve a cure for Type 1 diabetes before 2033?
- Will the FDA approve CagriSema?
- When will each party have 2 announced 2028 presidential candidates?
- When will Google release Gemini 3.5 Pro?
- When will Heavenly Mountain Resort open for the 26/27 winter season?
- When will nuclear fusion be achieved?
A price on DOXA is the market-implied probability of an outcome on the venue that lists it. It is what traders are paying, not a forecast made by DOXA, and it is not investment advice. How DOXA shows prices · Terms of Use
DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.